Relevant bibliographies by topics / Lactulose

Academic literature on the topic 'Lactulose'

Author: Grafiati
Published: 4 June 2021
Last updated: 22 June 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Lactulose.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Lactulose"

1

Tavares, Ricardo Silva, Barbara Rocha Gonçalves, Stanrley Viali Gomes, Pauliana Sousa Oliveira, Camila Botelho Miguel, and Wellington Francisco Rodrigues. "Probióticos e lactulose no tratamento da encefalopatia hepática - uma revisão sistemática." Revista Remecs - Revista Multidisciplinar de Estudos Científicos em Saúde 4, no. 6 (June 26, 2019): 12. http://dx.doi.org/10.24281/rremecs2526-2874.2019.4.6.12-17.

Full text
Abstract:
Tendo isso em vista, o objetivo do presente trabalho foi avaliar a eficácia do uso de probióticos e lactulose em pacientes portadores de EH. Foi realizada busca pelos artigos em bases eletrônicas de dados, limitando-se ao período de 2014-2018. A estratégia de busca utilizou os termos: “hepatic encephalopathy”, “probiotics” e “lactulose”. Os critérios de inclusão determinados foram grupos de indivíduos sob uso de probióticos e/ou lactulose como terapia e controle(placebo). Dos 200 artigos levantados nas plataformas de pesquisa, apenas cinco trabalhos foram selecionados. De acordo com os estudos analisados, observou-se melhora significativa na recuperação, efeitos adversos e qualidade de vida dos indivíduos sob tratamento à base de probióticos em comparação ao uso de placebos ou à ausência de tratamento. Além disso, a concentração de amônia plasmática foi menor em pacientes tratados com probióticos comparados aos pacientes que fizeram uso de lactulose.Descritores: Amônia, Neurotransmissor, tratamento.Probiotcs and lactulose in the treatment of hepatic encephalopathy - a systematicAbstract: With this in mind, the objective of this study was to evaluate the efficacy of probiotics and lactulose in patients with HS. A search for articles was conducted on electronic data bases, limiting the period of 2014-2018. The search strategy used the terms: "Hepatic encephalopathy", "Probiotics" and "lactulose". The inclusion criteria were groups of individuals under the use of probiotics and/or lactulose as therapy and control (placebo). Of the 200 articles raised on the research platforms, only five papers were selected. According to the studies analyzed, there was a significant improvement in the recovery, adverse effects and quality of life of the individuals under treatment based on probiotics compared to the use of placebos or the absence of treatment. In addition, plasma ammonia concentration was lower in patients treated with probiotics compared to patients who made use of lactulose.Descriptors: Ammonia, Neurotransmitter, Treatment.Probióticos y lactulose en tratamiento de la encefalopatía hepática - una revisiónResumen: Con esto en mente, el objetivo de este estudio fue evaluar la eficacia de los probióticos y lactulosa en pacientes con HS. Se realizó una búsqueda de artículos sobre bases de datos electrónicas, limitando el período de 2014-2018. La estrategia de búsqueda utiliza los términos: "encefalopatía hepática", "probióticos" y "lactulose". Los criterios de inclusión fueron grupos de individuos bajo el uso de probióticos y/o lactulosa como terapia y control (placebo). De los 200 artículos planteados en las plataformas de investigación, sólo se seleccionaron cinco artículos. De acuerdo con los estudios analizados, hubo una mejora significativa en la recuperación, efectos adversos y calidad de vida de los individuos bajo tratamiento basado en probióticos en comparación con el uso de placebos o la ausencia de tratamiento. Además, la concentración plasmática de amoníaco fue menor en los pacientes tratados con probióticos en comparación con los pacientes que hicieron uso de lactulose.Descriptores: Amoníaco, Neurotransmisor, Tratamiento.
APA, Harvard, Vancouver, ISO, and other styles
2

Hussain, Mazhar, Habib-Ur Rehman, Lubna Akhtar, and Muhammad Bilal Ghafoor. "HEPATIC ENCEPHALOPATHY;." Professional Medical Journal 24, no. 07 (July 3, 2017): 947–51. http://dx.doi.org/10.29309/tpmj/2017.24.07.1087.

Full text
Abstract:
Background: Hepatic encephalopathy is one of the fatal complications of livercirrhosis in clinical setting. A number of drugs with varied response have been tried up till now.Objectives: To compare the efficacy of lactulsoe alone and in combination with rifaxamin incases with hepatic encephalopathy. Study Design: Randomized control trail. Setting: SheikhZayed Hospital (SZH) Rahim Yar Khan (RYK). Period: January 2015 to October 2015. Patientsand Methods: 120 cases of liver cirrhosis with encephalopathy were randomized into differentgrades according to West Haven’s criteria. These cases were then equally divided into group Aand B. Group A was treated with lactulose alone while group B was treated with lactulose plusrifaxamin with their standard doses. The cases were assessed for their improvement in symptomson West Haven’s scale and the cases with complete resolution of symptoms were labeled ascured. The mortality benefit was also noted. Results: The mean age was 43.24± 8.34 yearsand mean duration of symptoms was 3.45± 0.8 days. There was no significant difference interms of child pugh score in both groups with p= 0.69. There was also no significant differencein both groups in terms of grades of encephalopathy (p= 0.21). However there was significantbetter efficacy and decreased mortality in group B as compared to A with p values of 0.02 and0.03 respectively. Conclusion: Lactulose combined with rifaxamin has significant improvementin encephalopathy as well as in reducing mortality in comparison with lactulsoe alone
APA, Harvard, Vancouver, ISO, and other styles
3

&NA;. "Lactulose." Reactions Weekly &NA;, no. 1176 (November 2007): 19–20. http://dx.doi.org/10.2165/00128415-200711760-00057.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

&NA;. "Lactulose." Reactions Weekly &NA;, no. 1364 (August 2011): 29. http://dx.doi.org/10.2165/00128415-201113640-00110.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Jankowski, Gwendolyn. "Lactulose." Journal of Exotic Pet Medicine 18, no. 2 (April 2009): 156–59. http://dx.doi.org/10.1053/j.jepm.2009.04.009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Lee, Gwenyth O., Peter Kosek, Aldo A. M. Lima, Ravinder Singh, Pablo P. Yori, Maribel P. Olortegui, Jesse L. Lamsam, Domingos B. Oliveira, Richard L. Guerrant, and Margaret Kosek. "Lactulose." Journal of Pediatric Gastroenterology and Nutrition 59, no. 4 (October 2014): 544–50. http://dx.doi.org/10.1097/mpg.0000000000000459.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

MCMEEKIN, JUDY. "LACTULOSE." Nursing 21, no. 6 (June 1991): 84–86. http://dx.doi.org/10.1097/00152193-199106000-00035.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Singh, Monika, Radha Kushwaha, Vinti Singh, Rahul Agrawal, Anil Parajapati, and Devinder Kaur. "Lactulose fortification in guava preserves: Effect on nutritional quality." Food and Health 9, no. 2 (2023): 98–107. http://dx.doi.org/10.3153/fh23009.

Full text
Abstract:
This study examined the lactulose-fortified low-calorie guava preserves. The results showed that sucrose, used as a sweetener in guava preserves, could be partially substituted by lactulose without significantly affecting the overall quality of the preserves. The physicochemical properties, antioxidant activity, and sensory evaluation of guava preserves with substitute lactulose were evaluated. The main aim of this study was to develop prebiotic guava preserves from two guava cultivars, namely, Safeda and Chittidar. The guava preserves without lactulose were used as control samples which contained 50% w/w sucrose of pulp, while lactulose-treated preserves replaced sucrose with 25%, 50%, and 75% w/w of lactulose. The finding showed that prebiotics did not significantly differ between control and treated samples. The range of ascorbic acid content of guava preserves was 98.2-102.6 mg/100g. Lactulose did not show a statistically significant effect on the level of ascorbic acid in guava preserves. The mineral content and antioxidant properties of guava preserves supplemented with lactulose were higher than those not supplemented with lactulose. The guava preserves with 50% lactulose were most accepted.
APA, Harvard, Vancouver, ISO, and other styles
9

Fu, Jian, Yi Gao, and Li Shi. "Combination therapy with rifaximin and lactulose in hepatic encephalopathy: A systematic review and meta-analysis." PLOS ONE 17, no. 4 (April 26, 2022): e0267647. http://dx.doi.org/10.1371/journal.pone.0267647.

Full text
Abstract:
Rifaximin and lactulose are widely used in patients with hepatic encephalopathy (HE); however, data on whether the combined use of rifaximin and lactulose could yield additional benefits for patients with HE are limited and inconclusive. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) to determine the treatment effectiveness of rifaximin plus lactulose versus lactulose alone in patients with HE. Electronic databases (PubMed, Embase, Cochrane Library, and China National Knowledge Infrastructure) were searched for eligible RCTs from their inception until November 2020. Relative risks (RRs) with 95% confidence intervals (CIs) were applied to calculate pooled effect estimates for the treatment effectiveness of rifaximin plus lactulose versus lactulose alone by using the random-effects model. Sensitivity, subgroup, and publication bias analyses were also performed. We included 7 RCTs enrolling 843 patients with HE. We noted that the use of rifaximin plus lactulose was associated with an increased incidence of effective rate than lactulose alone (RR, 1.30; 95% CI, 1.10–1.53; P = 0.002). Moreover, the use of rifaximin plus lactulose was associated with a reduced risk of mortality as compared with lactulose alone (RR, 0.57; 95% CI, 0.41–0.80; P = 0.001). This study found that the use of rifaximin in combination with lactulose could provide additional benefits in terms of increased effective rate and decreased mortality than lactulose alone in patients with HE.
APA, Harvard, Vancouver, ISO, and other styles
10

Fu, Jian, Yi Gao, and Li Shi. "Combination therapy with rifaximin and lactulose in hepatic encephalopathy: A systematic review and meta-analysis." PLOS ONE 17, no. 4 (April 26, 2022): e0267647. http://dx.doi.org/10.1371/journal.pone.0267647.

Full text
Abstract:
Rifaximin and lactulose are widely used in patients with hepatic encephalopathy (HE); however, data on whether the combined use of rifaximin and lactulose could yield additional benefits for patients with HE are limited and inconclusive. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) to determine the treatment effectiveness of rifaximin plus lactulose versus lactulose alone in patients with HE. Electronic databases (PubMed, Embase, Cochrane Library, and China National Knowledge Infrastructure) were searched for eligible RCTs from their inception until November 2020. Relative risks (RRs) with 95% confidence intervals (CIs) were applied to calculate pooled effect estimates for the treatment effectiveness of rifaximin plus lactulose versus lactulose alone by using the random-effects model. Sensitivity, subgroup, and publication bias analyses were also performed. We included 7 RCTs enrolling 843 patients with HE. We noted that the use of rifaximin plus lactulose was associated with an increased incidence of effective rate than lactulose alone (RR, 1.30; 95% CI, 1.10–1.53; P = 0.002). Moreover, the use of rifaximin plus lactulose was associated with a reduced risk of mortality as compared with lactulose alone (RR, 0.57; 95% CI, 0.41–0.80; P = 0.001). This study found that the use of rifaximin in combination with lactulose could provide additional benefits in terms of increased effective rate and decreased mortality than lactulose alone in patients with HE.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Lactulose"

1

Sahota, Surinder Singh. "The metabolism of lactulose by intestinal bacteria." Thesis, Royal Holloway, University of London, 1987. http://repository.royalholloway.ac.uk/items/b233ad63-a111-4eb6-95a0-4fce40b008d3/1/.

Full text
Abstract:
About 60 strains of intestinal bacteria were cultured in lactulose-containing media to quantitate both sugar fermentation and non-gaseous end-products. Certain species of Clostridia (especially C. perfringens), lactobacilli and bacteroides utilised the disaccharide extensively, while other organisms were unable to metabolise this substrate, beta-Galactosidase activity did not parallel growth on lactulose in all cases. The major fermentation products were acetic, lactic and butyric acids. Hydrogen and carbon dioxide were the only gases qualitatively detected. Clostridial strains exhibited a butyric type fermentation, and most lactobacilli were homofermentative. Fermentation products were estimated for selected species throughout their growth cycles. The products of lactulose fermentation by mixed bacterial cultures varied with incubation conditions such as pH, but correlated well with those produced by pure cultures. Studies on lactulose transport by C. perfringens indicated 14 methodological limitations in assaying (C) lactose uptake and in the use of NADH-based procedures. o-Nitrophenyl O-D-galactopyranoside uptake by lactulose grown whole cells and an absence of phospho-beta-D-galactosidase suggested an active transport of the disaccharide. The inducible beta-galactosidase was partially purified and characterised fructose 1,6-bisphosphate inhibited enzyme activity by 26%, and lactulose or lactose hydrolysis required K ions. Galactokinase was inducible in galactose, lactulose or lactose grown cells. Fructose 1-phosphate kinase (FIPK) and fructose 6-phosphate kinase were detected in fructose grown cell-free extracts; FIPK was partially purified five-fold by affinity chromatography. The glucose effect was observed in C. perfringens grown on lactulose, and could not be eleviated by external cyclic AMP or dibutyryl cAMP. Assays for the cyclic nucleotide in lactulose grown cells and extracellular fluid were in the negative. This inhibition was not observed during growth on a mixture of lactulose with fructose, and co-utilisation of lactulose with galactose and lactose respectively was apparent.
APA, Harvard, Vancouver, ISO, and other styles
2

Gimenez, Vidal Marc. "Isomérisation du lactose en lactulose par électro-activation." Thesis, Université Laval, 2013. http://www.theses.ulaval.ca/2013/29776/29776.pdf.

Full text
Abstract:
Dans le présent travail, l’électro-isomérisation du lactose en lactulose a été étudiée. Les variables indépendantes mises à l’étude dans ce projet sont : 1) l’effet de la concentration du lactose (5 et 10%), l’effet de la densité du champ électrique appliqué au réacteur d’électro-activation (100 et 200 mA). L’électro-isomérisation du lactose à 5% a été également comparée à celle observée dans du lactosérum ayant une concentration de lactose  5%. Les variables réponse principales (variables dépendantes) mises à l’étude étaient le taux de conversion du lactose en lactulose, le taux de formation de sous-produits de la réaction et l'efficacité du procédé exprimée en termes de résistance électrique globale du système d’électro-activation. Une surface totale de l’aire cathodique de 21,5 cm2 a été utilisée, donnant ainsi des densités de courant électrique de 4,65 et 9,30 mA/cm2, respectivement. Les analyses statistiques des données obtenues ont montré que l’effet du temps d’électro-activation sur le taux d’électro-isomérisation du lactose (rendement de formation de lactulose) ainsi que la résistance électrique du réacteur électro-activation était significatif. Le processus d’électro-activation a été réalisé pendant 60 min et des échantillons ont été prélevés chaque 10 min. Les résultats obtenus ont montré la grande efficacité de l'électro-activation, en tant qu’approche novatrice, pour transformer le lactose en lactulose. Après 60 min d’électro-activation à température ambiante (23  1  C), 25% de rendement d’électro-isomérisation a été obtenu. En excluant le lactose, la pureté du produit final était de 96,28  0,18%. En outre, aucune formation d’epilactose n’a été observée. De façon non systématique, du galactose a été détecté dans certains échantillons (<1,5%) et seulement quelques traces de fructose ont été observées (<0,31%). La résistance électrique globale du réacteur d’électro-activation diminuait avec l’augmentation du temps d'électro-activation, indiquant une grande efficacité énergétique de cette nouvelle technologie d’isomérisation du lactose en lactulose.
In the present work, electro-isomerization of lactose into lactulose has been studied. Effects of lactose concentration (5 and 10%) and applied DC-electric field (100 and 200 mA) on the electro-isomerization of lactose into lactulose and on process efficiency were investigated. Total cathode area of 21.5 cm2 was used; giving electric current density of 4.65 mA/cm2 and 9.30 mA/cm2, respectively. Milk whey permeate (4.7  0.15% lactose) obtained by ultrafiltration was also used as feed solution in the electro-activation reactor. The effect of processing time on lactose electro-isomerization rate (lactulose formation yield), by-product (glucose, galactose, epilactose and fructose) formation, and global electric resistance of the electro-activation reactor has been investigated. The process was run during 60 min and samples were taken every 10 min. Obtained results showed the high effectiveness of the developed electro-activation technology to convert lactose into lactulose. After 60 min electro-activation at ambient temperature (23  1 C), 25% electro-isomerisation yield was obtained. By excluding lactose, the end product purity was 96.28  0.18%, which is similar to the pharmakopoeia requirements for lactulose powder. Moreover, no epilactose was formed. Not systematically, galactose was detected in some samples (<1.5%) and only some traces of fructose were detected (<0.31%). The global electric resistance of the electro-activation reactor decreased as the electro-activation time was increased indicating the high energetic effectiveness of this new electro-isomerization technology.
APA, Harvard, Vancouver, ISO, and other styles
3

Bird, S. P. "Nutritional and metabolic effects of lactulose and lactitol." Thesis, University of Reading, 1986. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.373828.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Blanc, Pierre. "Efficacité du traitement par lactulose-néomycine dans l'encéphalopathie hépatique aigue͏̈ : étude randomisée en simple aveugle contre placebo." Montpellier 1, 1989. http://www.theses.fr/1989MON11105.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Harouch, Jamal. "Meta-analyse du traitement de l'encéphalopathie hépatique chronique." Montpellier 1, 1989. http://www.theses.fr/1989MON11312.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

MARTINEAU, LAURE. "Valorisation du lactose par voie chimique : synthese du lactulose." Rennes 1, 1989. http://www.theses.fr/1989REN10033.

Full text
Abstract:
Synthese du lactalose par isomerisation du lactose en milieu basique. Un procede de cristallisation du lactalose a ete mis au point. Apres isomerisation d'une partie lactospe contenue dans les permeats de lait, il est possible de reconstituer le lait par ajout des retentats d'ultrafiltration. Des essais en quart de grand, apres demineralisation partielle, permettent de penser que ces laits supporteront les traitements thermiques habituels
APA, Harvard, Vancouver, ISO, and other styles
7

Andrews, G. R. "The lactulose content and colour of UHT and sterilized milks." Thesis, University of Reading, 1986. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.373754.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Luginbühl, Martin. "Kulturelle Beeinfluss obligat und fakultativ anaerober Darmkeime durch Lactulose und Lactitol /." [S.l : s.n.], 1986. http://www.ub.unibe.ch/content/bibliotheken_sammlungen/sondersammlungen/dissen_bestellformular/index_ger.html.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Pickard, Mark Richard. "The metabolism of lactulose by Clostridium perfringens in batch and continuous culture." Thesis, Royal Holloway, University of London, 1988. http://repository.royalholloway.ac.uk/items/d2446a6b-78f0-4aa9-a8ea-ff9fdc5ff6a0/1/.

Full text
Abstract:
The aim of this project was to initiate studies on lactulose (4-O-[beta]-D-galactopyranosyl D-fructofuranose) metabolism by human intestinal bacteria. The organism of choice was Cl. perfringens, due to its rapid metabolism of the sugar. Work was conducted with cells grown anaerobically, in both batch and continuous culture. Use of the latter system permitted closer approximation of the in vivo situation. Initial work was concerned with the identification of the metabolic pathway(s) involved. Radiolabelled lactulose was not available, hence a variety of 'cold' procedures were employed; including fluorimetric determination of key metabolites, and assay of key enzymes. Growth in medium supplemented with lactulose resulted in the induction ofB-galactosidase, whereas phospho-B-galactosidase activity could not be detected. This suggested that lactulose was accumulated in the free form and that the first step in intracellular metabolism was hydrolysis to its constituent monosaccharides. This was confirmed by the detection of intracellular free galactose and fructose. The galactosyl moiety was found to be metabolised by the Leloir pathway: the enzymes galactokinase, galactose 1-phosphate uridylyl transferase and UDPgalactose 4-epimerase were present in lactulose-grown cells, and both galactose 1-phosphate and glucose 1-phosphate were detected. The fructosyl moiety was most likely metabolised by an ATP-dependent fructokinase activity, present in lactulose-grown cells. Measurement of lactulose utilisation in a buffered incubation system permitted the study of various transport system inhibitors. Utilisation was inhibited by both CCCP and DCCD, suggesting that transport requires a proton gradient; formed by the action of the membrane-bound ATPase activity. The presence of a proton gradient-dependent uptake system is consistent with the findings from the metabolic studies. A similar metabolic system was responsible for lactulose metabolism under conditions of carbon limitation in the chemostat. Galactokinase was further studied. Basal levels of this enzyme were repressed by inclusion of glucose in the culture medium. Glucose also prevented induction of galactokinase by lactulose or galactose. This latter 'glucose effect' could not be abolished by the addition of cyclic AMP, and appeared to be mediated via inducer exclusion.
APA, Harvard, Vancouver, ISO, and other styles
10

Wyss, André. "Wirkung von Lactulose und Lactitol auf pH, Ammoniakkonzentration und Gesamtkeimzahl in Stuhlsuspensionen /." [S.l : s.n.], 1987. http://www.ub.unibe.ch/content/bibliotheken_sammlungen/sondersammlungen/dissen_bestellformular/index_ger.html.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Lactulose"

1

Hepatic encephalopathy: Management with lactulose and related carbohydrates. East Lansing, Mich: Medi-Ed Press, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Conn, Harold O. Hepatic Encephalopathy: Management With Lactulose and Related Carbohydrates. Medi-ed Pr, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Publications, ICON Health. Lactulose - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References. ICON Health Publications, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hepatic encephalopathy: Syndromes and therapies. Bloomington, Ill: Medi-Ed Press, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Conn, Harold O. Hepatic Encephalopathy: Syndromes and Therapies. Medi-ed Pr, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Keshav, Satish, and Alexandra Kent. Investigation in gastrointestinal disease. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0195.

Full text
Abstract:
This chapter discusses investigation in gastrointestinal (GI) disease, including blood tests (full blood count, haematinics, biochemistry, immunology, microbiology, stool investigations), radiology (abdominal plain X-rays, barium studies, ultrasound, CT, MRI), nuclear medicine (SeHCAT scan, HIDA scan, gastric emptying study), endoscopy (oesophagogastroduodenoscopy, lower GI endoscopy, endoscopic retrograde cholangiopancreatography, therapeutic endoscopy, capsule endoscopy), and breath tests (lactulose/glucose-hydrogen breath test, lactose/hydrogen breath test, urea breath test).
APA, Harvard, Vancouver, ISO, and other styles
7

Vogt, Janet Anne. An evaluation of the effects of the colonic fermentation of L-rhamnose and lactulose on biosynthesis and serum concentrations of cholesterol and triacylglycerol-fatty acids and serum short-chain fatty acids in humans. 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Lactulose"

1

Bährle-Rapp, Marina. "Lactulose." In Springer Lexikon Kosmetik und Körperpflege, 309. Berlin, Heidelberg: Springer Berlin Heidelberg, 2007. http://dx.doi.org/10.1007/978-3-540-71095-0_5779.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Guerrero, Cecilia, Carlos Vera, and Andrés Illanes. "Lactulose." In Handbook of Food Bioactive Ingredients, 1413–48. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-28109-9_38.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Guerrero, Cecilia, Carlos Vera, and Andrés Illanes. "Lactulose." In Handbook of Food Bioactive Ingredients, 1–36. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-81404-5_38-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Faccioli, Jessica, Stefania Gioia, Silvia Nardelli, Oliviero Riggio, and Lorenzo Ridola. "Lactulose in Liver Cirrhosis." In Pharmacotherapy for Liver Cirrhosis and Its Complications, 223–40. Singapore: Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-2615-0_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hazra, Tanmay, Rohit G. Sindhav, Sudheendra V. K. Chaganti, and Subhash Prasad. "Lactulose: Production And Techno-Functional Applications." In Functional Dairy Ingredients and Nutraceuticals, 3–25. Boca Raton: Apple Academic Press, 2022. http://dx.doi.org/10.1201/9781003277309-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Olano, A., M. Ramos, J. A. Suarez, and S. L. Lopez-Covarrubias. "Yogurt Made from Milk with Added Lactulose." In MILK the vital force, 204. Dordrecht: Springer Netherlands, 1986. http://dx.doi.org/10.1007/978-94-009-3733-8_169.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Weber, Fredrick L. "Treatment of Hepatic Encephalopathy with Lactulose and Antibiotics." In Hepatic Encephalopathy, 483–507. Totowa, NJ: Humana Press, 1989. http://dx.doi.org/10.1007/978-1-4612-4506-3_34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Harju, M. "Hydrolysis of Lactulose and Lactitol with β-Galactosidases." In MILK the vital force, 232. Dordrecht: Springer Netherlands, 1986. http://dx.doi.org/10.1007/978-94-009-3733-8_191.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

van den Heuvel, E. G. H. M., Th Muijs, W. van Dokkum, and G. Schaafsma. "Lactulose Stimulates Calcium Absorption in Postmenopausal Women Dose-Dependently." In Trace Elements in Man and Animals 10, 441. New York, NY: Springer US, 2002. http://dx.doi.org/10.1007/0-306-47466-2_136.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Hammer, J., H. F. Hammer, K. Lang, R. Lipp, K. Kletter, and A. Gangl. "Colonic Transit in Lactulose and Polyethylene Glycol Induced Osmotic Diarrhea." In Radioactive Isotopes in Clinical Medicine and Research, 245–50. Basel: Birkhäuser Basel, 1997. http://dx.doi.org/10.1007/978-3-0348-7772-5_36.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Lactulose"

1

Mahardhika, Andhika Bintang, Yoshella Novelynda, and Sophi Damayanti. "Validation of spectrophotometric method for lactulose assay in syrup preparation." In THE 5TH INTERNATIONAL CONFERENCE ON MATHEMATICS AND NATURAL SCIENCES. AIP Publishing LLC, 2015. http://dx.doi.org/10.1063/1.4930770.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Avtandilyan, N. G., R. R. Halkechev, and Aleksei Lodygin. "FORMATION OF REQUIREMENTS FOR THE COMPOSITION AND PHYSICOCHEMICAL PARAMETERS OF LACTOSE-CONTAINING RAW MATERIALS FOR THE PRODUCTION OF LACTULOSE CONCENTRATES." In I International Congress “The Latest Achievements of Medicine, Healthcare, and Health-Saving Technologies”. Kemerovo State University, 2023. http://dx.doi.org/10.21603/-i-ic-4.

Full text
Abstract:
The relevance of lactulose concentrates development for the production of functional foods is substantiated. The results of studies of the effect of the amount of an alkaline catalyst of the isomerization reaction on the physico-chemical parameters of permeates of secondary dairy raw materials are presented.
APA, Harvard, Vancouver, ISO, and other styles
3

Yusuf, Fauzi, Wahyuni, Azzaki Abubakar, and Desi Maghfirah. "Comparison of the Effectiveness in Administration of Lactulose, Probiotics and a Combination of Lactulose and Probiotics against Hepatic Encephalopathy in Patients with Liver Cirrhosis." In The 2nd Syiah Kuala International Conference on Medicine and Health Sciences. SCITEPRESS - Science and Technology Publications, 2018. http://dx.doi.org/10.5220/0008791000680071.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Evdokimov, Ivan, Aleksei Lodygin, and Georgi S. Anisimov. "CREATION OF RUSSIAN HIGH-TECHNOLOGY MANUFACTURING OF LACTOSE AND LACTULOSE INTENDED FOR IMPORT SUBSTITUTION IN MEDICINE, VETERINARY, INFANT FOOD AND HEALTHY NUTRITION." In I International Congress “The Latest Achievements of Medicine, Healthcare, and Health-Saving Technologies”. Kemerovo State University, 2023. http://dx.doi.org/10.21603/-i-ic-41.

Full text
Abstract:
The Russian high-technology manufacturing of lactose of food and pharmaceutical grades is presented. Technology of prebiotic lactulose is being created using lactose as a raw material. The concept of lactose and its derivatives producing from various types of the basis lactose-containing raw materials for import substitution in medicine, veterinary, infant food and healthy nutrition has been developed.
APA, Harvard, Vancouver, ISO, and other styles
5

Higashi, Bruna, Sheila Mara Sanches Lopes, Regina Aparecida Correia Gonçalves, and Arildo José Braz de Oliveira. "Estudo Comparativo da Propriedade Prebiótica da Inulina Versus Xarope de Lactulose." In Simpósio de Bioquímica e Biotecnologia. Londrina - PR, Brazil: Galoa, 2017. http://dx.doi.org/10.17648/simbbtec-2017-80964.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

LIma, Ítalo Abreu, Hewerton Barbosa Gomes, Douglas Roberto Guimarães da Silva, Aline Pereira Martins, Eduardo Mendes Ramos, Roberta Hilsdorf Piccoli, and Alcinéia de Lemos Souza Ramos. "Qualidade Microbiológica Nas Etapas de Presunto Cru de Suíno Adicionado de Lactulose." In XII Latin American Congress on Food Microbiology and Hygiene. São Paulo: Editora Edgard Blücher, 2014. http://dx.doi.org/10.5151/foodsci-microal-174.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

"#11 – ORAL LACTULOSE IS SUPERIOR TO POLYETHYLENE GLYCOL FOR COLONOSCOPY BOWEL PREPARATION." In Semana Panamericana de Enfermedades Digestivas. SPED 2023. Editorial Iku Limitada, 2023. http://dx.doi.org/10.46613/congastro2023-11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

ALBUQUERQUE, T. L., A. P. D'ALMEIDA, L. H. A. SILVA, N. C. G. SILVA, L. R. B. GONÇALVES, and M. V. P. ROCHA. "SÍNTESE SIMULTÂNEA DE LACTULOSE E ETANOL UTILIZANDO O SORO DE LEITE COMO SUBSTRATO." In XXII Congresso Brasileiro de Engenharia Química. São Paulo: Editora Blucher, 2018. http://dx.doi.org/10.5151/cobeq2018-pt.0923.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Gunn, David, Caroline Yeldho, Caroline Hoad, Luca Marciani, and Robin Spiller. "O55 Lactulose increases small bowel but not colonic water content; questioning the osmotic laxative dogma." In Abstracts of the BSG Campus, 21–29 January 2021. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2021. http://dx.doi.org/10.1136/gutjnl-2020-bsgcampus.55.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Hotta, Naoki. "IDDF2019-ABS-0096 The use of elobixibat and lactulose for bowel preparation for colon capsule endoscopy." In International Digestive Disease Forum (IDDF) 2019, Hong Kong, 8–9 June 2019. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2019. http://dx.doi.org/10.1136/gutjnl-2019-iddfabstracts.141.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Lactulose"

1

Mossine, Valerie V. Multivalent Lactulose-amines as Inhibitors of Prostate Cancer Metastasis. Fort Belvoir, VA: Defense Technical Information Center, March 2002. http://dx.doi.org/10.21236/ada406249.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Shippee, Ronald L., Avery A. Johnson, William G. Cioffi, James Lasko, and Thomas E. LeVoyer. Simultaneous Determination of Lactulose and Mannitol in Urine of Burn Patients by Gas-Liquid Chromatography. Fort Belvoir, VA: Defense Technical Information Center, January 1992. http://dx.doi.org/10.21236/ada251648.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Zheng, You-you, Ning Liang, Long-kun Liu, Wei-jia Sun, Xue-hui Wang, Yu-xin Sun, Yun-ru Chen, Xiao-xia Han, Zhao-lan Liu, and Jian-ping Liu. Effectiveness and Safety of Chinese Patent Medicine for Functional Constipation: A Systematic Review and Network-Meta Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2022. http://dx.doi.org/10.37766/inplasy2022.5.0049.

Full text
Abstract:
Review question / Objective: To evaluate the effectiveness and safety of Chinese patent medicine in treatment of functional constipation by using the Network Meta-Analysis. 1. Types of participants: participants diagnosed as functional constipation according to Rome III, Rome IV or other published criteria or guidelines. No limitation on types of FC, age, sex, and nation. Children and pregnant women were excluded. Participants who had other constipation-related diseases including irritable bowel syndrome, functional defecation disorders and opioid-induced constipation were excluded. 2 Types of Interventions. Chinese patent medicine which have been registered with the approval batch number beginning with “Z,” approved by Chinese National Medical Product Administration (NMPA), used alone or in combination with Polyethylene Glycol, Lactulose, Bisacodyl, Prucalopride Succinate, probiotic, or Mosapride which recommended by latest clinical guidelines released by authorized organizations. The dosage, formulation, and route of administration of Chinese patent medicine were not limited. 3 Types of control. Registered Chinese patent medicines used alone, Polyethylene Glycol, Lactulose, Bisacodyl, Prucalopride Succinate, probiotic, Mosapride which recommended by latest clinical guidelines released by authorized organizations or placebo were eligible. 4 Types of outcomes. Primary outcomes were the clinical effect, score of dyschezia and defecation time. Secondary outcomes were adverse events and recurrence rate. 5 Types of study design. Parallel randomized controlled trials (RCTs) were included. Conference abstracts were excluded if full articles were not available.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Lactulose' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography